Tylenol Extra Strength Caplets yesterday became the latest in a long succession of Johnson & Johnson products to be pulled from the shelves after complaints of the pills’ “musty odor”.
US Government Officials have implored ten major pharmaceutical companies to give up information in the race to solve the 2007-2008 contaminated Chinese herparin incident.
DSM Biologicals has launched a new production method designed to streamline downstream processing during biopharmaceutical manufacturing that, it claims, makes making mAB-based drugs more cost effective.
Gerresheimer will expand its pharmaceutical packaging plant in the Czech Republic to meet growing demand for plastic systems and to further expand a key training hub.
Contract manufacturing organisation (CMO) Neuland Laboratories will showcase its expanded capabilities for synthetic peptide manufacture at the 22nd American Peptide Symposium to be held in San Diego, US later this week.
Sponsors should bring together vendors before a trial begins and have them share information and experiences that will make the project successful, said a consultant at DIA.
Catalent Pharma Solutions and German expression system developer Cevec Pharmaceuticals have partnered to create a cell development service that, they claim, will help drugmakers generate stable lines faster.
Symetic has opened a new lab facility to showcase its range of processing systems to the pharmaceutical manufacturing, packaging and nutraceutical sectors.
Switzerland-based life sciences supplier Lonza says it will invest CHF10m (€8m) to expand a Singapore plant that is part of its custom biomanufacturing business.
Indian CRAMS firm Jubilant Life Sciences has renamed HollisterStier Contract Manufacturing and hired a new BD exec in latest stage of North American reorganisation.
Ubichem Fine Chemicals has sold a majority stake in Ubichem Research, which provides chemistry services to drug developers through its Ubichem Pharma Services, to investment group Lochlomond Holding.
The European Union (EU) formally adopted the falsified medicines directive at the weekend, giving member states 18 months to makes the document's anti-counterfeiting track and trace measures into national law.
UK-based contract manufacturing organisation (CMO) SCM Pharma has struck a deal with urology experts Speciality European Pharma (SEP) to help bring SEP's oncology product, Plenaxis, to the European market.
The US Food and Drug Administration (FDA) has published a list of all the drug manufacturing facilities it has inspected between October 2008 and September 2010 as part of Government transparency efforts.
Florida-based contract manufacturing organisation (CMO), Goodwin Biotechnology (GBI), has entered into an agreement with protein and monoclonal antibody drug developer, Rafagen, to provide cell line engineering and biological contract manufacturing services.
